Northwire Canada EditionThursday, July 23, 2026
Northwire
VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2% VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2%
Financings

Surenano arranges debt settlement, private placement

SURE · Price

Executive Summary

  • Surenano Science Ltd. announced a recapitalization strategy involving a debt settlement with insider Charles Malette for $85,000 and a private placement raising up to $215,000, totaling up to 3 million shares at $0.10 per share.
  • The company held its Annual General and Special Meeting (AGSM) on August 8, 2025, where shareholders unanimously re-elected four directors, appointed Buckley Dodds CPA as auditor, and approved an omnibus long-term incentive plan.
  • Proceeds from the private placement will be used for operating expenses, including legal, audit fees, and general working capital, with a four-month-and-one-day hold period on issued securities.

Key Details

  • Debt Settlement:
    • Settled with insider/director Charles Malette.
    • Total value: $85,000.
    • Exempt from valuation and minority shareholder approval under National Instrument 61-101 (amount less than 25% of capitalization).
    • Post-settlement ownership: Mr. Malette will own 8,521,600 shares, representing 34.8% of the common shares then issued.
  • Private Placement:
    • Maximum proceeds: $215,000.
    • Price per share: $0.10.
    • Total shares to be issued (combined with debt settlement): Up to 3,000,000 shares.
    • Investors: Arm's-length investors.
    • Hold Period: Four months and one day for all securities issued in the private placement.
    • Use of Proceeds: Operating expenses, including legal and audit fees, and general working capital.
  • Annual General and Special Meeting (AGSM) Results:
    • Date: August 8, 2025.
    • Quorum: 10 shareholders voted (in person or by proxy), representing 15,083,100 common shares (70.29% of issued and outstanding shares).
    • Director Elections: Unanimous election of all four directors standing for election.
    • Auditor Appointment: Unanimous appointment of Buckley Dodds CPA as the company's auditor.
    • Incentive Plan: Unanimous approval of the company's omnibus long-term incentive plan.

Notable Quotes

  • No direct quotes from the CEO/President were included in the provided text.
Read the original news release →

More from Surenano Science Ltd